Published in BMJ on March 02, 2004
Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother (2005) 3.49
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care (2013) 3.40
Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother (2010) 2.34
Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa. Mayo Clin Proc (2011) 1.89
Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence. Antimicrob Agents Chemother (2013) 1.85
Combination therapy for treatment of infections with gram-negative bacteria. Clin Microbiol Rev (2012) 1.84
Risk of AKI with gentamicin as surgical prophylaxis. J Am Soc Nephrol (2014) 1.78
Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults. Can J Infect Dis Med Microbiol (2008) 1.68
Systematic review and meta-analysis of in vitro synergy of polymyxins and carbapenems. Antimicrob Agents Chemother (2013) 1.27
Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance Summit. Clin Infect Dis (2011) 1.22
Advances in the management of sepsis and the understanding of key immunologic defects. Anesthesiology (2011) 1.21
Influence of empiric therapy with a beta-lactam alone or combined with an aminoglycoside on prognosis of bacteremia due to gram-negative microorganisms. Antimicrob Agents Chemother (2010) 1.05
Antibiotic prescription patterns in the empiric therapy of severe sepsis: combination of antimicrobials with different mechanisms of action reduces mortality. Crit Care (2012) 1.05
Bacteriophage therapy and the mutant selection window. Antimicrob Agents Chemother (2008) 1.05
Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases. Infection (2016) 0.97
Rapid identification of pathogens in positive blood culture of patients with sepsis: review and meta-analysis of the performance of the sepsityper kit. Int J Microbiol (2015) 0.94
Advances in antibiotic therapy in the critically ill. Crit Care (2016) 0.94
Bench-to-bedside review: antimicrobial utilization strategies aimed at preventing the emergence of bacterial resistance in the intensive care unit. Crit Care (2005) 0.93
[Diagnosis and therapy of sepsis]. Clin Res Cardiol (2006) 0.87
[Diagnosis and treatment of infective endocarditis. Current ESC guidelines]. Herz (2010) 0.87
Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy. BMC Infect Dis (2014) 0.86
An alternate pathophysiologic paradigm of sepsis and septic shock: implications for optimizing antimicrobial therapy. Virulence (2013) 0.86
Pseudomonas aeruginosa AmpR: an acute-chronic switch regulator. Pathog Dis (2015) 0.86
Overcoming drug resistance in multi-drug resistant cancers and microorganisms: a conceptual framework. Bioengineered (2012) 0.86
Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO). Ann Hematol (2014) 0.84
Outcomes of appropriate empiric combination versus monotherapy for Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother (2012) 0.83
Combination therapy versus monotherapy: a randomised pilot study on the evolution of inflammatory parameters after ventilator associated pneumonia [ISRCTN31976779]. Crit Care (2006) 0.83
Surviving Sepsis in the Intensive Care Unit: The Challenge of Antimicrobial Resistance and the Trauma Patient. World J Surg (2017) 0.83
Cefotetan versus conventional triple antibiotic prophylaxis in elective colorectal cancer surgery. J Korean Med Sci (2010) 0.82
Role of Pseudomonas aeruginosa AmpR on β-lactam and non-β-lactam transient cross-resistance upon pre-exposure to subinhibitory concentrations of antibiotics. J Med Microbiol (2014) 0.81
A survey on infection management practices in Italian ICUs. Crit Care (2012) 0.80
Sepsis Associated Encephalopathy. Adv Med (2014) 0.80
Current strategies for the prevention and management of central line-associated bloodstream infections. Infect Drug Resist (2010) 0.80
Principles and strategies of antimicrobial stewardship in the neonatal intensive care unit. Semin Perinatol (2012) 0.79
Current concepts in combination antibiotic therapy for critically ill patients. Indian J Crit Care Med (2014) 0.79
Comparison of clinical prediction models for resistant bacteria in community-onset pneumonia. Acad Emerg Med (2015) 0.79
Section 3: Prevention and Treatment of AKI. Kidney Int Suppl (2011) (2012) 0.78
Impact of combination therapy with aminoglycosides on the outcome of ICU-acquired bacteraemias. Eur J Clin Microbiol Infect Dis (2012) 0.78
In vitro activity of colistin in antimicrobial combination against carbapenem-resistant Acinetobacter baumannii isolated from patients with ventilator-associated pneumonia in Vietnam. J Med Microbiol (2015) 0.78
Impact of definitive therapy with beta-lactam monotherapy or combination with an aminoglycoside or a quinolone for Pseudomonas aeruginosa bacteremia. PLoS One (2011) 0.78
Safety and feasibility of antibiotic de-escalation in bacteremic pneumonia. Infect Drug Resist (2014) 0.77
Impact of adequate empirical combination therapy on mortality from bacteremic Pseudomonas aeruginosa pneumonia. BMC Infect Dis (2012) 0.77
Beneficial antimicrobial effect of the addition of an aminoglycoside to a β-lactam antibiotic in an E. coli porcine intensive care severe sepsis model. PLoS One (2014) 0.77
Propensity-based study of aminoglycoside nephrotoxicity in patients with severe sepsis or septic shock. Antimicrob Agents Chemother (2014) 0.75
Retrospective survey and evaluation of first-line antibiotics for chemotherapy-induced febrile neutropenia in patients with acute myeloid leukemia. Nagoya J Med Sci (2017) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA (1995) 45.41
Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med (2001) 9.08
Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest (1999) 7.40
Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med (1991) 5.85
Diagnosis and management of infective endocarditis and its complications. Circulation (1999) 4.77
The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med (1998) 4.48
Infections in cancer patients. Results with gentamicin sulfate therapy. Cancer (1972) 4.47
The ACCP-SCCM consensus conference on sepsis and organ failure. Chest (1992) 4.35
Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med (1989) 3.98
Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: a randomized study. Meropenem Lower Respiratory Infection Group. Crit Care Med (1997) 2.84
Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study. Ann Intern Med (1982) 2.52
Significance of antimicrobial synergism for the outcome of gram negative sepsis. Am J Med Sci (1977) 2.28
Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study. Antimicrob Agents Chemother (1997) 2.00
Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome. Crit Care Med (2003) 1.89
Synergistic combinations of antibiotics in gram-negative bacillary infections. Rev Infect Dis (1982) 1.62
Single or combination therapy of staphylococcal endocarditis in intravenous drug abusers. Ann Intern Med (1979) 1.58
Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy. Antimicrob Agents Chemother (1992) 1.57
Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections. Hepatology (1985) 1.50
Single-drug versus combination empirical therapy for gram-negative bacillary infections in febrile cancer patients with and without granulocytopenia. Antimicrob Agents Chemother (1984) 1.41
Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions. Am J Med (1986) 1.38
Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients. Antimicrob Agents Chemother (1994) 1.37
Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis. BMJ (2003) 1.35
Therapy with carbenicillin and gentamicin for patients with cancer and severe infections caused by gram-negative rods. Cancer (1973) 1.20
Combination therapy as a tool to prevent emergence of bacterial resistance. Infection (1999) 1.17
Synergism between tobramycin and ceftazidime against a resistant Pseudomonas aeruginosa strain, tested in an in vitro pharmacokinetic model. Antimicrob Agents Chemother (1997) 1.16
Broad spectrum penicillin as an adequate therapy for acute cholangitis. Surg Gynecol Obstet (1990) 1.15
A randomized, controlled trial of cefoperazone vs. cefamandole-tobramycin in the treatment of putative, severe infections with gram-negative bacilli. Rev Infect Dis (1983) 1.11
Treatment of infections in hospitalized patients with ticarcillin plus clavulanic acid. A comparative study. Am J Med (1985) 1.07
In vitro synergistic activities of aminoglycosides and new beta-lactams against multiresistant Pseudomonas aeruginosa. Antimicrob Agents Chemother (1984) 1.06
Comparison of once daily ceftriaxone with gentamicin plus cefuroxime for treatment of serious bacterial infections. Lancet (1988) 1.04
Diagnostic and therapeutic management of nosocomial pneumonia in surgical patients: results of the Eole study. Crit Care Med (2002) 1.03
Prospective randomized comparison of mezlocillin therapy alone with combined ampicillin and gentamicin therapy for patients with cholangitis. Arch Intern Med (1989) 1.03
Cefotaxime compared with nafcillin plus tobramycin for serious bacterial infections. A randomized, double-blind trial. Ann Intern Med (1984) 1.02
Antibiotics in infections of the biliary tract. Surg Gynecol Obstet (1987) 1.00
Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial. The Severe Generalized Peritonitis Study Group. Antimicrob Agents Chemother (2000) 0.98
Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group. Clin Infect Dis (1998) 0.98
Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial. Ann Intern Med (1996) 0.97
Therapy of staphylococcal infections with cefamandole or vancomycin alone or with a combination of cefamandole and tobramycin. Antimicrob Agents Chemother (1983) 0.95
A prospective randomized trial of ceftazidime versus cefazolin/tobramycin in the treatment of hospitalized patients with pneumonia. J Antimicrob Chemother (1987) 0.91
A prospective randomized trial of ceftazidime versus netilmicin plus mezlocillin in the empirical therapy of presumed sepsis in cirrhotic patients. Hepatology (1997) 0.91
Ceftazidime versus tobramycin/ticarcillin in treating hospital acquired pneumonia and bacteremia. Pharmacotherapy (1984) 0.90
Cefepime for infections of the biliary tract. Surg Gynecol Obstet (1993) 0.90
Ability of azlocillin and tobramycin in combination to delay or prevent resistance development in Pseudomonas aeruginosa. J Antimicrob Chemother (1999) 0.89
Pseudomonas aeruginosa bacteremia: an analysis of 123 episodes, with particular emphasis on the effect of antibiotic therapy. Int J Infect Dis (1998) 0.87
Pharmacodynamics of antibacterial drugs. Infect Dis Clin North Am (2000) 0.85
A nationwide survey of antibiotic prescribing patterns and clinical outcomes in patients with bacterial pneumonia. DICP (1990) 0.85
[Prospective, randomized, controlled study of imipenem-cilastatin versus cefotaxime-amikacin in the treatment of lower respiratory tract infection and septicemia at intensive care units]. Presse Med (1990) 0.84
Empirical monotherapy with meropenem in serious bacterial infections. Meropenem Study Group. J Antimicrob Chemother (1995) 0.84
Efficacy of meropenem as monotherapy in the treatment of ventilator-associated pneumonia. J Chemother (2001) 0.84
Effectiveness of mezlocillin and endotracheally administered sisomicin with or without parenteral sisomicin in the treatment of Gram-negative bronchopneumonia. J Antimicrob Chemother (1982) 0.83
Aminoglycosides for intra-abdominal infection: equal to the challenge? Surg Infect (Larchmt) (2002) 0.82
Aminoglycosides do not improve the efficacy of cephalosporins for treatment of acute pyelonephritis in women. Scand J Infect Dis (1997) 0.82
Cefoperazone compared with ampicillin plus tobramycin for severe biliary tract infections. Antimicrob Agents Chemother (1988) 0.82
Ceftazidime monotherapy vs. ceftriaxone/tobramycin for serious hospital-acquired gram-negative infections. Antibiotic Study Group. Clin Infect Dis (1995) 0.81
A randomized trial of three antibiotic regimens for the treatment of pyelonephritis in pregnancy. Obstet Gynecol (1998) 0.80
Analysis of aminoglycosides in the treatment of gram-negative infections in surgical patients. Arch Surg (1999) 0.80
Effect of ampicillin, chloramphenicol, and penicillin-streptomycin in acute cholecystitis. Scand J Gastroenterol (1973) 0.78
A prospective randomised comparison of cefotaxime vs. netilmicin vs. cefotaxime plus netilmicin in the treatment of hospitalised patients with serious sepsis. Scand J Infect Dis (1987) 0.78
Efficacy, safety, and tolerance of piperacillin/tazobactam compared to co-amoxiclav plus an aminoglycoside in the treatment of severe pneumonia. Eur J Clin Microbiol Infect Dis (1998) 0.78
Ceftazidime versus tobramycin-ticarcillin in the treatment of pneumonia and bacteremia. Antimicrob Agents Chemother (1985) 0.77
Ceftazidime versus aminoglycoside and (ureido)penicillin combination in the empirical treatment of serious infection. J R Soc Med (1992) 0.77
[Efficacy and costs of treatment with ceftriaxone compared to ampicillin-gentamycin in acute pyelonephritis]. Rev Med Suisse Romande (1991) 0.77
[Ceftriaxone or combined cefazolin-gentamicin for complicated urinary tract infections]. Harefuah (1990) 0.77
Ceftazidime versus a combination of amikacin and ticarcillin in the treatment of severe infections. Clin Ther (1988) 0.77
Azlocillin versus azlocillin plus amikacin in the treatment of severe infections in intensive care unit patients. Chemioterapia (1987) 0.77
[Comparison of the efficacy of cefotaxime alone and the combination cefazolin-tobramycin in the treatment of enterobacterial septicemia]. Pathol Biol (Paris) (1987) 0.77
[Clinical evaluation of ceftazidime and the combined administration of cefotaxime and tobramycin in the treatment of urinary tract infections. Prospective and randomized studies]. Pol Tyg Lek (1986) 0.77
[Clinical evaluation of combination therapy of sulbactam/cefoperazone and aminoglycoside in respiratory tract infections]. Jpn J Antibiot (1994) 0.77
Randomized comparison of ceftriaxone versus ceftriaxone plus amikacin for the empirical treatment of infections in patients with altered host defense: microbiological and clinical evaluation. Chemotherapy (1992) 0.76
Cefotaxime (C) vs cefotaxime + amikacin (C + A) in the treatment of septicemia due to enterobacteria: a multicenter study. Chemioterapia (1987) 0.76
A randomized study of cefepime versus the combination of gentamicin and mezlocillin as an adjunct to surgical treatment in patients with acute cholecystitis. Surg Gynecol Obstet (1993) 0.76
[Amoxicillin and clavulanic acid versus amoxicillin plus gentamicin in the empirical initial treatment of urinary tract infections in hospitalized patients]. Schweiz Med Wochenschr (1995) 0.76
Treatment of serious urological infections with cefotaxime compared to ampicillin plus netilmicin. Dan Med Bull (1986) 0.76
A comparative study of two antibiotic regimens for the treatment of operative site infections. Am J Obstet Gynecol (1982) 0.76
Meropenem versus cefuroxime plus gentamicin for treatment of serious infections in elderly patients. Antimicrob Agents Chemother (1998) 0.76
[Imipenem/cilastatin sodium alone or combined with amikacin sulfate in respiratory infections]. Jpn J Antibiot (1994) 0.76
[Multicenter open randomized trial of meropenem in comparison to ceftazidime and amikacin used in combination in severe hospital infections]. Antibiot Khimioter (1998) 0.76
Imipenem/cilastatin as empirical treatment of severe infections in compromised patients. J Chemother (1991) 0.76
[Comparative clinical trial of cefoperazone versus ampicillin + tobramycin in severe bronchopulmonary and pleural infectious pathology]. Rev Pneumol Clin (1985) 0.76
Randomized multicenter clinical trial with imipenem/cilastatin versus cefotaxime/gentamicin in the treatment of patients with non-life-threatening infections. German and Austrian Imipenem/Cilastatin Study Group. Eur J Clin Microbiol Infect Dis (1992) 0.76
Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials. J Natl Cancer Inst (2009) 3.83
Systematic comparison of four sources of drug information regarding adjustment of dose for renal function. BMJ (2005) 3.51
Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients. Ann Intern Med (2005) 3.10
Efficacy and safety of cefepime: a systematic review and meta-analysis. Lancet Infect Dis (2007) 3.09
Efficacy and safety of tigecycline: a systematic review and meta-analysis. J Antimicrob Chemother (2011) 2.86
Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals. Microb Pathog (2012) 2.85
Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother (2010) 2.34
Deworming drugs for soil-transmitted intestinal worms in children: effects on nutritional indicators, haemoglobin, and school performance. Cochrane Database Syst Rev (2015) 2.24
Deworming drugs for soil-transmitted intestinal worms in children: effects on nutritional indicators, haemoglobin and school performance. Cochrane Database Syst Rev (2012) 2.16
Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials. Vaccine (2007) 2.14
Dose-dense chemotherapy in nonmetastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials. J Natl Cancer Inst (2010) 1.99
Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial. J Antimicrob Chemother (2006) 1.88
Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother (2005) 1.88
Deworming drugs for soil-transmitted intestinal worms in children: effects on nutritional indicators, haemoglobin and school performance. Cochrane Database Syst Rev (2012) 1.84
Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis. J Clin Oncol (2007) 1.82
Systematic review: comparative effectiveness and harms of combination therapy and monotherapy for dyslipidemia. Ann Intern Med (2009) 1.80
Prophylactic antibiotics for burns patients: systematic review and meta-analysis. BMJ (2010) 1.78
Pragmatic vs explanatory trials: the pragmascope tool to help measure differences in protocols of mental health randomized controlled trials. Dialogues Clin Neurosci (2011) 1.74
Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials. Mayo Clin Proc (2007) 1.73
Treatment of human brucellosis: systematic review and meta-analysis of randomised controlled trials. BMJ (2008) 1.73
Interventions for alleviating cancer-related dyspnea: a systematic review. J Clin Oncol (2008) 1.72
Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother (2010) 1.71
Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials. J Clin Endocrinol Metab (2006) 1.69
Empirical atypical coverage for inpatients with community-acquired pneumonia: systematic review of randomized controlled trials. Arch Intern Med (2005) 1.67
Antibiotic prophylaxis in cardiac surgery: systematic review and meta-analysis. J Antimicrob Chemother (2011) 1.67
PCR diagnosis of invasive candidiasis: systematic review and meta-analysis. J Clin Microbiol (2010) 1.59
Influenza vaccines in immunosuppressed adults with cancer. Cochrane Database Syst Rev (2013) 1.56
Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction: a systematic review and meta-analysis. Ann Intern Med (2009) 1.53
Pharmacological interventions for fertility preservation during chemotherapy: a systematic review and meta-analysis. Breast Cancer Res Treat (2010) 1.53
Immunoglobulin prophylaxis in hematopoietic stem cell transplantation: systematic review and meta-analysis. J Clin Oncol (2008) 1.52
Intermittent drug techniques for schizophrenia. Cochrane Database Syst Rev (2013) 1.51
Clinical implications of β-lactam-aminoglycoside synergism: systematic review of randomised trials. Int J Antimicrob Agents (2011) 1.51
Comparative efficacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis. Antimicrob Agents Chemother (2009) 1.47
Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis (2008) 1.45
Applying an artificial neural network to warfarin maintenance dose prediction. Isr Med Assoc J (2004) 1.43
Antibiotic prophylaxis in neutropenic patients. Isr Med Assoc J (2007) 1.43
Infective endocarditis in diabetic and non-diabetic patients. Scand J Infect Dis (2004) 1.42
Intravenous versus oral iron supplementation for the treatment of anemia in CKD: systematic review and meta-analysis. Am J Kidney Dis (2008) 1.42
Voxel-based morphometry for separation of schizophrenia from other types of psychosis in first episode psychosis. Cochrane Database Syst Rev (2015) 1.42
Effectiveness and safety of colistin: prospective comparative cohort study. J Antimicrob Chemother (2010) 1.42
Life skills programmes for chronic mental illnesses. Cochrane Database Syst Rev (2012) 1.42
Transcranial magnetic stimulation (TMS) for schizophrenia. Cochrane Database Syst Rev (2015) 1.40
Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis. BMJ (2003) 1.35
Systematic review and meta-analysis of in vitro synergy of polymyxins and carbapenems. Antimicrob Agents Chemother (2013) 1.27
Benefit of appropriate empirical antibiotic treatment: thirty-day mortality and duration of hospital stay. Am J Med (2006) 1.25
Treatment modalities for Graves' ophthalmopathy: systematic review and metaanalysis. J Clin Endocrinol Metab (2009) 1.24
Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy. Cochrane Database Syst Rev (2012) 1.22
The impact of Bevacizumab (Avastin) on survival in metastatic solid tumors--a meta-analysis and systematic review. PLoS One (2013) 1.20
Vasopressin receptor antagonists for the treatment of hyponatremia: systematic review and meta-analysis. Am J Kidney Dis (2010) 1.19
A model for diagnosis of pulmonary infections in solid-organ transplant recipients. Comput Methods Programs Biomed (2010) 1.19
Evidence of intestinal inflammation in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr (2010) 1.17
Systematic review and meta-analysis of the clinical safety and tolerability of ibuprofen compared with paracetamol in paediatric pain and fever. Curr Med Res Opin (2009) 1.16
Empirical antibiotics against Gram-positive infections for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother (2005) 1.14
Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding. Cochrane Database Syst Rev (2010) 1.12
Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother (2007) 1.11
Vaccines for preventing typhoid fever. Cochrane Database Syst Rev (2014) 1.11
Antimicrobial agents for treating uncomplicated urinary tract infection in women. Cochrane Database Syst Rev (2010) 1.10
Medicalisation: peering from inside medicine. BMJ (2002) 1.09
Intravenous iron supplementation for the treatment of chemotherapy-induced anaemia - systematic review and meta-analysis of randomised controlled trials. Acta Oncol (2012) 1.04
Three-day vs longer duration of antibiotic treatment for cystitis in women: systematic review and meta-analysis. Am J Med (2005) 1.04
Treatment of invasive candidal infections: systematic review and meta-analysis. Mayo Clin Proc (2008) 1.03
Risk factors and a clinical index for diagnosis of Pseudomonas aeruginosa bacteremia. Clin Microbiol Infect (1995) 1.03
Effect of quinolone prophylaxis in afebrile neutropenic patients on microbial resistance: systematic review and meta-analysis. J Antimicrob Chemother (2006) 1.03
Co-trimoxazole-sensitive, methicillin-resistant Staphylococcus aureus, Israel, 1988-1997. Emerg Infect Dis (2003) 1.01
Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis. Cochrane Database Syst Rev (2014) 1.01
A systematic review of interventions to increase awareness, knowledge, and folic acid consumption before and during pregnancy. Am J Health Promot (2008) 1.01
Reporting of adverse events in randomized controlled trials of highly active antiretroviral therapy: systematic review. J Antimicrob Chemother (2009) 1.00
Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-analysis. Eur J Heart Fail (2012) 1.00
Benefit of early treatment with oseltamivir in hospitalized patients with documented 2009 influenza A (H1N1): retrospective cohort study. J Antimicrob Chemother (2011) 1.00
Thrombocytopenia in Staphylococcus aureus bacteremia: risk factors and prognostic importance. Mayo Clin Proc (2011) 0.99
Immunoglobulin prophylaxis in chronic lymphocytic leukemia and multiple myeloma: systematic review and meta-analysis. Leuk Lymphoma (2009) 0.99
PCR using blood for diagnosis of invasive pneumococcal disease: systematic review and meta-analysis. J Clin Microbiol (2009) 0.99
Psychosocial interventions for the prevention of relapse in bipolar disorder: systematic review of controlled trials. Br J Psychiatry (2008) 0.99
Treatment of anemia in inflammatory bowel disease--systematic review and meta-analysis. PLoS One (2013) 0.99
Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database Syst Rev (2014) 0.96
Duration of antibiotic treatment for acute pyelonephritis and septic urinary tract infection-- 7 days or less versus longer treatment: systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother (2013) 0.95
Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients. Cochrane Database Syst Rev (2013) 0.94
Combination antibiotic therapy for Pseudomonas aeruginosa bacteraemia. Lancet Infect Dis (2005) 0.94
Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients: a systematic review and meta-analysis of randomized trials. J Antimicrob Chemother (2004) 0.93
Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams. Cochrane Database Syst Rev (2010) 0.92
Empirical antifungal therapy for patients with neutropenia and persistent fever: Systematic review and meta-analysis. Eur J Cancer (2008) 0.92
Antibiotics for preventing meningococcal infections. Cochrane Database Syst Rev (2011) 0.91
Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database Syst Rev (2012) 0.91
Systematic review of cholinergic drugs for neuroleptic-induced tardive dyskinesia: a meta-analysis of randomized controlled trials. Prog Neuropsychopharmacol Biol Psychiatry (2004) 0.91
Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study. J Antimicrob Chemother (2010) 0.91
Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB). Cochrane Database Syst Rev (2012) 0.91
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia. Cochrane Database Syst Rev (2013) 0.90
Immunoglobulin prophylaxis in hematological malignancies and hematopoietic stem cell transplantation. Cochrane Database Syst Rev (2008) 0.90
Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB). Cochrane Database Syst Rev (2009) 0.90
Antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhotic patients with ascites, without gastro-intestinal bleeding. Cochrane Database Syst Rev (2009) 0.90
Propensity-matched analysis of appropriate empirical antibiotic treatment. Clin Infect Dis (2007) 0.89
Aromatherapy for dementia. Cochrane Database Syst Rev (2014) 0.89
Interventions for alleviating cancer-related dyspnea: a systematic review and meta-analysis. Acta Oncol (2012) 0.89
Diagnostic accuracy of PCR alone compared to galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis: a systematic review. J Clin Microbiol (2012) 0.88
Oral sildenafil citrate (viagra) for erectile dysfunction: a systematic review and meta-analysis of harms. Urology (2009) 0.88
The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988-2004. Isr Med Assoc J (2007) 0.88